SABS Market Cap & Key Metrics
SAB Biotherapeutics, Inc.
$2.49
-$0.19(-7.09%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$226.56M
Volume
853.13K
52W Range
$2.10 - $5.15
Target Price
$11.82
SABS market cap is $226.56M. This page lists SAB Biotherapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
SABS Key Metrics
- Market cap
- $226.56M
- EPS estimate, current year
- $-1.17
- EPS growth, 3-year
- +27.06%
- Value score
- 60
- Quality score
- 21
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $1.32M | $2.24M | $23.90M | $60.88M |
| EBITDA | $16.60M | -$29.33M | -$38.60M | -$15.12M | -$15.49M |
| EPS | $0.22 | $-3.68 | $-7.64 | $-4.30 | $-6.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SABS | $2.49 | -7.1% | 853.13K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get SAB Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW